Hepatitis B surface antigen and antibody. A prospective study in asymptomatic drug abusers.
The course of reactivity of hepatitis B surface antigen (HBsAg) and antibody (anti-HBs) in 238 asymptomatic heroin addicts entering methadone maintenance was followed up for periods of one to four years. On initial determination, HBsAg was seen in 39.1%, anti-HBs in 10.5%, and HBsAg and anti-HBs in 9.2%; only 41.2% of persons tested had no detectable titers of either antigen or antibody. Abnormal liver function was found initially in 83% with no significant difference between those with or without HBsAg and anti-HBs. At the conclusion of each study year, 50% to 60% of persons initially HBsAg-positive reverted to negative with HBsAg absent in all persons followed up through the fourth year of treatment. Anti-HBs persisted in two thirds of persons during the entire study. These results suggest that the HBsAg carrier state in addicts is not maintained if exposure is eliminated.
D000293:Adolescent; D000328:Adult; D000906:Antibodies / Q000032:analysis*; D002353:Carrier State / Q000276:immunology; D002462:Cell Membrane / Q000276:immunology; D002908:Chronic Disease; D003378:Counterimmunoelectrophoresis; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000276:immunology*; D006510:Hepatitis B Antibodies / Q000032:analysis*; D006511:Hepatitis B Antigens / Q000032:analysis*; D006556:Heroin Dependence / Q000276:immunology; D006801:Humans; D005779:Immunodiffusion; D008111:Liver Function Tests; D008875:Middle Aged; D011446:Prospective Studies; D013997:Time Factors
D000906:Antibodies; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens